Scientific and
Strategic Partners

spanning AI-driven vaccine design, advanced delivery technologies, and GMP-grade circular RNA manufacturing.

Vaxxirna retains full ownership of its platform and intellectual property. Our partnerships are structured to accelerate execution, reduce operational risk, and bring the highest-quality capabilities to bear at each stage of development.

Our Partnership Philosophy

We partner with intent. Each collaboration is chosen for its direct
contribution to platform performance, manufacturing readiness, or
clinical execution — not for breadth. Our partners are experts in
their respective domains, and we work with them as extensions of
the Vaxxirna team.

Partner With Us

Vaxxirna is open to engagement with organizations whose capabilities
complement our platform, including contract development and
manufacturing organizations (CDMOs), academic institutions, AI and
computational biology groups, and global health organizations.

Contact Us